Later, a study revealed that ARL4D expression in gliomas is dependent on the loss of PTEN tumor suppressor and consequent activation of the Akt/mammalian Target of Rapamycin (mTOR) pathway (Chi et al., 2008). This evidence concerns the gene MTOR and neoplasm.